Ravi Kumar Chaudhary
Government Institute of Medical Sciences, Sanford-Burnham Medical Research Institute, Gautam Buddha University, Sheffield Hallam University, Institute of Applied Medicines & Research
About
Dr. Ravi Kumar Chaudhary is a dedicated researcher specializing in molecular diagnostics, regenerative medicine, and personalized healthcare. He holds a Ph.D. in Biotechnology and MTech in Genetic Engineering. He ahs published his research findings in peer-reviewed journals including Acta Biomaterialia, Frontiers in Neuroscience, Molecular Neurobiology, ACS Omega, International Journal of Infectious Diseases, Current Pharmaceutical Design etc. He is an active member and reviewer for several journals and organizations like Frontiers in Molecular Neuroscience, Molecular Neurobiology, Springer, International Skill Development Council, PLOS One, International Journal of Microbiology, Wiley, BioMed Research International, Hindawi. ABRCMS, American Society of Microbiology etc. His scholarly contributions include peer-reviewed publications, book chapters, and presentations at international conferences.
He has developed innovative diagnostic tools, including real-time and nanoprobe-based assays for infectious and non-communicable diseases. His research on in vivo cellular reprogramming and transdifferentiation aims to enhance regenerative therapies for diseases like diabetes. He has been instrumental in advancing medical diagnostics through novel approaches such as molecular beacon-based PCR arrays and nanoparticle-based biosensors. His expertise has been recognized through awards and fellowships, including the Young Investigator Award from the Bill & Melinda Gates Foundation.
He continues to contribute to translational medicine, combining academic rigor with technological innovation to improve global health outcomes. His future vision is to contribute towards a healthier world by revolutionizing early & cost-effective diagnostics and personalized medicine through cutting-edge research. His mission is to leverage science and technology in the service of mankind, promoting health equity and making the earth a better and healthier place to live. He aims to play a crucial role in the future of precision medicine and contribute towards a world where health solutions are both innovative and accessible to all.
Employment
-
Government Institute of Medical Sciences Senior Scientist2023 - Present
-
Sanford-Burnham Medical Research Institute Postdosctoral Associate2022 - 2023
-
Government Institute of Medical Sciences Scientist-D2020 - 2022
-
Institute of Applied Medicines & Research Assistant Professor2019 - 2020
-
Gautam Buddha University Senior Research Fellow2014 - 2015
-
Gautam Buddha University Junior Research Fellow2012 - 2014
Education
-
Gautam Buddha University PhD2013 - 2019
-
Sheffield Hallam University Post Graduate Certificate in Biosciences (PgC)2011 - 2012
-
Gautam Buddha University Master of Technology (M.Tech.)2010 - 2012
-
Institute of Applied Medicine and Research Master of Science (M.Sc.)2007 - 2009
-
Govt. P. G. College, Noida Bachelor of Science (B. Sc.)2004 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (19)
- The Applications of Biosensors and Biochips for Prognosis and Diagnosis of Diseases Save
- Nanoparticles-mediated Brain Imaging and Disease Prognosis by Conventional as well as Modern Modal Imaging Techniques: a Comparison. Save
- Bioinformatics Techniques for Drug Discovery Save
- Study of toxin-antitoxin proteins in Pseudomonas aeruginosa persisters and genetic engineering approaches for their effective treatment Save
- Deciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology Approach Save
- Nanomaterial approaches for imaging and treating Alzheimer Disease Save
- The role of toxin-antitoxin systems in the survival of multidrug tolerant pathogens and designing of new approaches to treat them Save
- Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases Save
- Nanoparticles in practice for molecular-imaging applications: An overview Save
- Culture free detection of Escherichia coli O157 by using milk protein coated activated charcoal (MP-CAC) based pathogen concentrator and qPCR. Save